InvestorsHub Logo
Followers 271
Posts 15407
Boards Moderated 1
Alias Born 03/28/2013

Re: None

Tuesday, 01/11/2022 7:07:02 AM

Tuesday, January 11, 2022 7:07:02 AM

Post# of 458185
In a report released today, Soumit Roy from JonesTrading reiterated a Buy rating on Anavex Life Sciences (AVXL – Research Report), with a price target of $50.00. The company's shares closed last Monday at $15.05. According to TipRanks.com, Roy is a 5-star analyst with an average return of 18.5% and a 34.0% success rate. Roy covers the Healthcare sector, focusing on stocks such as Deciphera Pharmaceuticals, Adaptimmune Therapeutics, and Monopar Therapeutics Inc. Anavex Life Sciences has an analyst consensus of Strong Buy, with a price target consensus of $39.80. See Insiders’ Hot Stocks on TipRanks >> The company has a one-year high of $31.50 and a one-year low of $5.12.

https://www.tipranks.com/news/blurbs/jonestrading-reaffirms-their-buy-rating-on-anavex-life-sciences-avxl?utm_source=advfn.com&utm_medium=referral
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News